HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manfred Blobner Selected Research

Atracurium (Tracrium)

8/2013Prolonged administration of pyridostigmine impairs neuromuscular function with and without down-regulation of acetylcholine receptors.
3/2010Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness.
6/2007Long-term effects of botulinum toxin on neuromuscular function.
11/2005Nitric oxide is not a mediator of inflammation-induced resistance to atracurium.
1/2003Systemic inflammation leads to resistance to atracurium without increasing membrane expression of acetylcholine receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manfred Blobner Research Topics

Disease

9Inflammation (Inflammations)
11/2018 - 01/2003
7Paralysis (Palsy)
08/2020 - 01/2003
5Ischemia
01/2020 - 02/2002
4Muscle Weakness
11/2016 - 03/2008
4Delayed Emergence from Anesthesia
11/2010 - 03/2006
3Critical Illness (Critically Ill)
01/2021 - 03/2010
3Alzheimer Disease (Alzheimer's Disease)
01/2019 - 02/2010
3Brain Ischemia (Cerebral Ischemia)
10/2003 - 02/2002
2Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2021 - 01/2020
2Wounds and Injuries (Trauma)
08/2020 - 01/2019
2Amyloid Plaque
01/2020 - 01/2019
2Necrosis
01/2020 - 01/2017
2Pain (Aches)
12/2019 - 01/2019
2Acute Coronary Syndrome
01/2019 - 10/2017
2Cognitive Dysfunction
01/2019 - 01/2017
2Air Embolism (Gas Embolism)
12/2011 - 04/2006
2Neurologic Manifestations (Neurological Manifestations)
11/2009 - 04/2006
2Hypotension (Low Blood Pressure)
10/2003 - 02/2003
1Bradycardia
10/2021
1Sinus Tachycardia
10/2021
1Out-of-Hospital Cardiac Arrest
01/2021
1Acute Kidney Injury (Acute Renal Failure)
12/2019
1Atrophic Muscular Disorders
11/2018
1Seizures (Absence Seizure)
11/2017
1Venous Thrombosis (Deep-Vein Thrombosis)
10/2017
1Pulmonary Embolism
10/2017
1Dyskinesias (Dyskinesia)
03/2015
1Hemorrhage
11/2014
1Anaphylaxis (Anaphylactic Shock)
11/2014
1Anemia
11/2014
1Venous Thromboembolism
11/2014
1Poisoning
08/2013
1Acidosis
02/2013
1Lactic Acidosis
02/2013
1Postoperative Cognitive Complications
01/2013
1Cerebral Infarction
12/2011
1Brain Diseases (Brain Disorder)
09/2011
1Sepsis (Septicemia)
09/2011
1Stroke (Strokes)
03/2011
1Hyperthermia
09/2010

Drug/Important Bio-Agent (IBA)

6SugammadexIBA
10/2021 - 10/2009
5Atracurium (Tracrium)FDA Link
08/2013 - 01/2003
4Rocuronium (Zemuron)FDA LinkGeneric
10/2021 - 10/2009
4salicylhydroxamic acid (SHAM)IBA
11/2018 - 02/2002
4Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2016 - 01/2003
4Cholinergic ReceptorsIBA
03/2010 - 01/2003
3Neostigmine (Neostigmine Bromide)IBA
10/2021 - 10/2010
3Pharmaceutical PreparationsIBA
11/2017 - 01/2003
3Glutamic Acid (Glutamate)FDA Link
11/2017 - 02/2002
3IsofluraneFDA LinkGeneric
10/2013 - 02/2003
3Neurotransmitter Agents (Neurotransmitter)IBA
09/2011 - 02/2002
3Anesthetics (Anesthetic Agents)IBA
02/2010 - 10/2003
2Caspase 3 (Caspase-3)IBA
01/2020 - 01/2017
2Oxygen (Dioxygen)IBA
12/2019 - 02/2003
2Amyloid beta-PeptidesIBA
01/2019 - 01/2017
2Fentanyl (Sublimaze)FDA LinkGeneric
01/2019 - 02/2003
2Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric
08/2013 - 03/2010
2XenonIBA
12/2011 - 04/2006
2Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2011 - 11/2005
2Neuroprotective AgentsIBA
09/2010 - 04/2006
2Glycoproteins (Glycoprotein)IBA
03/2008 - 01/2003
2Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2003 - 02/2002
2CatecholaminesIBA
10/2003 - 02/2002
2DexmedetomidineFDA Link
02/2003 - 02/2002
1Vecuronium Bromide (Vecuronium)FDA LinkGeneric
10/2021
1Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
10/2021
1Troponin T (Troponin T1)IBA
01/2021
1AlbuminsIBA
08/2020
1Glutamate Receptors (Glutamate Receptor)IBA
01/2020
1Ringer's acetateIBA
12/2019
1Opioid Analgesics (Opioids)IBA
01/2019
1Morphine (MS Contin)FDA LinkGeneric
01/2019
1Analgesics (Analgesic Drugs)IBA
01/2019
1MethemoglobinIBA
11/2018
13-(2,4-dimethoxybenzylidene)anabaseineIBA
11/2018
1gamma-Aminobutyric Acid (GABA)IBA
11/2017
1Antifibrinolytic Agents (Antifibrinolytics)IBA
11/2017
1Tranexamic Acid (AMCA)FDA Link
11/2017
1omega-Chloroacetophenone (Mace)IBA
10/2017
1Biomarkers (Surrogate Marker)IBA
10/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017
1Hemoglobins (Hemoglobin)IBA
11/2014
1Cholinesterase Inhibitors (Anticholinesterases)IBA
08/2013
1Nerve AgentsIBA
08/2013
1Lactic Acid (Lactate)FDA LinkGeneric
02/2013
1ChloridesIBA
02/2013
1Hematoxylin (Haematoxylon)IBA
01/2013
1Eosine Yellowish-(YS) (Eosin)IBA
01/2013
1Botulinum Toxins (Botulinum Toxin)IBA
01/2012
1Nitric Oxide Synthase (NO Synthase)IBA
09/2011
1Moxifloxacin (Avelox)FDA Link
03/2011

Therapy/Procedure

5Length of Stay
01/2021 - 03/2008
5Cardiopulmonary Bypass (Heart-Lung Bypass)
12/2011 - 04/2006
4Deep Hypothermia Induced Circulatory Arrest
03/2011 - 04/2006
2Therapeutics
01/2020 - 12/2019
1Resuscitation
01/2021
1Orthopedic Procedures
08/2020
1Injections
11/2016
1Laparoscopic Cholecystectomy
03/2015
1Anesthesia
01/2013